Tulsa Cancer Institute, PLLC — Tulsa, Oklahoma

Tulsa Cancer Institute, PLLC is a clinical research site located in Tulsa, Oklahoma, United States 74146.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Tulsa Cancer Institute, PLLC has participated in 2 clinical trials.

Therapeutic areas: Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV.

Sponsors: Synta Pharmaceuticals Corp., Merrimack Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tulsa Cancer Institute, PLLC?

Tulsa Cancer Institute, PLLC has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tulsa Cancer Institute, PLLC conducted?

Tulsa Cancer Institute, PLLC has 2 clinical trials on record. Their work covers Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV.

Is Tulsa Cancer Institute, PLLC accredited by Crixeo Health?

Tulsa Cancer Institute, PLLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tulsa Cancer Institute, PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.